FDA Grants Breakthrough Device Designation for Hemoglobin Variant Test
The test uses miniaturized electrophoresis technology designed to enable decentralized access to quantitative hemoglobin data.
Read MorePosted by CLP Edit Staff | Feb 9, 2026 | Hematology Instrumentation |
The test uses miniaturized electrophoresis technology designed to enable decentralized access to quantitative hemoglobin data.
Read MorePosted by CLP Edit Staff | Feb 6, 2026 | Cancer, Diagnostic Technologies, Lab Management |
New Labcorp survey of 152 oncologists reveals 89% expect care to become more complex within three years, while digital integration and coverage barriers persist.
Read MorePosted by CLP Edit Staff | Feb 3, 2026 | Infectious Diseases |
Vanderbilt Medical Laboratories has implemented in-house rapid antigen testing for histoplasmosis, reducing turnaround times and improving patient management, according to clinical staff and recent case reports.
Read MorePosted by CLP Edit Staff | Feb 2, 2026 | Flow Cytometry |
The test offers sensitivity comparable to next-generation sequencing methods while using noninvasive blood specimens instead of bone marrow aspirates.
Read MorePosted by CLP Edit Staff | Feb 2, 2026 | Mass Spectrometry |
Labcorp will deploy Roche’s cobas Mass Spec platform in its US labs, marking the first commercial rollout of this fully automated mass spectrometry system to streamline complex diagnostic testing workflows.
Read More